Does Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Sol Interact with Nonselective Beta Adrenergic Antagonists?
Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Sol and Nonselective Beta Adrenergic Antagonists have a major drug interaction according to U.S. FDA drug labeling data. Potential additive effects of beta-blockade both systemically and on intraocular pressure. Concomitant use of two topical beta-adrenergic blocking agents is not recommended. The mechanism involves additive beta-blockade effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Sol and Nonselective Beta Adrenergic Antagonists occurs because additive beta-blockade effects. Clinically, this means potential additive effects of beta-blockade both systemically and on intraocular pressure. concomitant use of two topical beta-adrenergic blocking agents is not recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Sol and your doctor is considering prescribing Nonselective Beta Adrenergic Antagonists (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider